Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al., Mul- tisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95.
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
Lancellotti P, Mélon P, Sakalihasan N, Waleffe A, Dubois C, Bertholet M et al. Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol 2004;94:1462-5.
Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-6.
Díaz-Infante E, Mont L, Leal J, García-Bolao I, Fernández-Lozano I, Hernaéndez-Madrid A et al., SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-40.
Yu CM, Gorcsan J 3rd, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS et al. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol 2007;100:1263-70.
Bleeker GB, Kaandorp TAM, Lamb JH, Boersma E, Steendijk P, de Roos A et al. Effect of posterolateral scar tissue on clinical and echocardio- graphic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.
Lim P, Bars C, Mitchell-Hegg L, Roiron C, Elbaz N, Hamdaoui B et al. Importance of contractile reserve for CRT. Europace 2007;9:739-43.
Lancellotti P, Hoffer EP, Pieérard LA. Detection and clinical usefulness of a biphasic response during exercise echocardiography early after myocar- dial infarction. J Am Coll Cardiol 2003;41:1142-7.
Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834- 40.
Ypenburg C, Sieders A, Bleeker GB, Holman ER, van der Wall EE, Schalij MJ et al. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J 2007;154:1160-5.
Lancellotti P, Cosyns B, Pieérard LA. Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure. Europace 2008;10:496-501.
Pitzalis MV, Iacoviello M, Romito R, Guida P, De Tommasi E, Luzzi G et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. JAm Coll Cardiol 2005;45:65-9.
Notabartolo D, Merlino JD, Smith AL, DeLurgio DB, Vera FV, Easley KA et al. Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy. Am J Cardiol 2004;94:817-20.
Lancellotti P, Stainier PY, Lebois F, Piérard LA. Effect of dynamic left venricular dyssynchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am J Cardiol 2005;96:1304-7.
Ryf S, Rutz AK, Boesiger P, Schwitter J. Is post-systolic shortening a reliable indicator of myocardial viability? An MR tagging and late-enhancement study. J Cardiovasc Magn Reson 2006;8:445-51.
Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
Ramahi TM, Longo MD, Cadariu AR, Rohlfs K, Slade M, Carolan S et al. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. Eur Heart J 2001;22:849-56.
Hummel JP, Lindner JR, Belcik JT, Ferguson JD, Mangrum JM, Bergin JD et al. Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm 2005;2:1211-7.
Da Costa A, Thévenin J, Roche F, Faure E, Roméyer-Bouchard C, Messier M et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm 2006;3:406-13.
Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P et al. Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J Nucl Med 2006;47:1565-70.
Chalil S, Foley PWX, Muyhaldeen SA, Patel KC, Yousef ZR, Smith RE et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 2007;9:1031-7.
Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41.
Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 2001;104:3069-75.
